| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5617802 | Journal of Vascular Surgery | 2017 | 8 Pages |
Abstract
Antiplatelet therapy with salicylates appears to be linked to a decreased risk of sac growth >5Â mm over time in patients with T2Es detected right after EVAR. Population-based cohort studies are mandatory to confirm this finding and to guide a potential recommendation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Francisco MD, MSc, José Manuel MD, PhD, Francisco José MD, Ahmad Amer MD, Jorge MD, PhD, Manuel MD, PhD, Santiago MD,